The global stroke management market is anticipated to reach market size of around US$ 50,000 Mn by 2027 and is projected to grow at a CAGR of around 6% in terms of revenue during the forecast period 2020 – 2027.
Blood circulation to the brain or whenever a blood vessel is explosive and bleeding, a stroke takes place. Blockage or breakage prohibits blood and oxygen from supplying the membranes of the brain. Blood scarcity and oxygen cause brain cells to die. An ischemic stroke is also a shock caused by blood supply interruption to the brain. The stroke caused by blood vessel bursting is considered a hemorrhagic stroke. According to CDC (Centers for Disease Control and Prevention), a third type is caused by sudden coagulation, called a transient ischemic attack (TIA). Stroke is the fifth largest cause of death in the US. Around 795,000 people had a stroke in the U.S. each year.
The proliferation in unhealthy lifestyles, alcohol and smoking abuse has lead to a cumulative spike in the prevalence in stroke. Around 40% of the U.S. geriatric community (aged 55 and older) suffers from a stroke, according to the Americas Medical Association. About 17 million deaths caused by stroke are estimated annually by the health organization. In the U.S., about 0.7 million people are affected by strokes per year, the Centers for Disease Control and Prevention said. The increase in stroke fuel prevalence contributes to overall demand growth. By splitting the market into the product category, function and region, the stroke treatment market is projected. Furthermore, diagnosis and therapy products are listed as products. In the growth of this industry, rising knowledge among individuals and medical professionals plays a significant role. The recognition has grown and compensated of the highest market share in 2019 for the rise in the incidence of stroke diagnosis. The diagnostic section will also attain CAGR the quickest during the projected timeframe with growing technical improvement and with patients seeking a preventive diagnosis. The provision of effective care recommendations guarantees proper treatment that inhibits the overall demand for stroke control. The American Heart Association has worked on recommendations that will assist doctors in the proper management of heard loss with the Heart Rhythm Society, the American Academy of Family Physicians, and the International Society for Heart & Lung Transplant. These recommendations provide the cornerstone for proper clinical treatment. The development of this demand could, however, conflict with high treatment rates and tight public policy to accept new advanced diagnostic technology.
The hemorrhagic section would be due to the increase in the hemorrhagic stroke about 6% in the forecast period around the globe. Growing demand for minimally invasive treatments for treating ischemic stroke, such as stereotactic radiology, would also result in demand for stroke control systems. The bleeding cavity of two forms is hemorrhagic haemorrhage, intracerebral and subarachnoid. The most frequent hemorrhagic stroke is intracerebral haemorrhage. Around 10-15% of the overall intracerebral blood disease is intracerebral, increasing substantial need for surgical hemorrhagic stroke treatment.
During the forecast period, North America will be the leading region. The US was the best in the area for its new health care system as well as the availability of qualified doctors and a high per capita healthcare budget. The second big market is projected in Europe. The primary reasons for this include a desirable payment environment, an improvement in geriatrics and increased spending by key actors. Due to large patient numbers, heavy use of tobacco, increased incidence of chronic diseases and significant changes in healthcare services, Asia Pacific will expand steadily over projected time frames. During the appraisal phase, the Latin America region would expand dramatically. In the anticipated timeframe, the field of the Middle East & Africa is expected to advance dramatically.
Some of the industry players include B. Braun Melsungen, Abbott Laboratories, GE Healthcare, Asahi Intecc CO., Boston Scientific, Siemens, Medtronic, Koninklijke Philips N.V., Johnson & Johnson, and others. These market players undertake numerous organic and inorganic development initiatives to reach higher business sales. In order to provide a wider analysis of the major players in the stroke control industry, the study offers market share assessments for firms. The study also contains main industry competitive changes, such as acquisitions & mergers, new product launch, alliances, partnerships, collaborations and joint ventures, research and growth, geographic expansion of existing global and regional players active in the stroke management market.
The global stroke management market is segmented as below:
Market Segmentation
Stroke Management Market By Type
Ischemic
Hemorrhagic
Transient ischemic attack (TIA)
Others
Stroke Management Market By Diagnostics
Magnetic resonance imaging (MRI)
Computed tomography scan (CT scan)
Electrocardiography
Carotid ultrasound
Cerebral angiography
Others
Stroke Management Market By Therapeutic Devices
Stent retriever
Surgical clipping
Embolic coils
Flow diverters
Aspiration catheters
Others
Stroke Management Market By End-use
Hospitals
Ambulatory surgical centers
Diagnostic centers
Others
Stroke Management Market By Geography
North America
Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Chapter 1. Industry Overview of Stroke Management
1.1 Definition and Scope
1.1.1 Definition of Stroke Management
1.1.2 Market Segmentation
1.1.3 Years Considered for the Study
1.1.4 Assumptions and Acronyms Used
1.1.4.1 Market Assumptions and Market Forecast
1.1.4.2 Acronyms Used In Global Stroke Management Market
1.2 Summary
1.2.1 Executive Summary
1.2.2 Stroke Management Market By Type
1.2.3 Global Stroke Management Market By Diagnostics
1.2.4 Global Stroke Management Market By Therapeutic Devices
1.2.5 Global Stroke Management Market By End User
1.2.6 Global Stroke Management Market by Regions
Chapter 2. Research Approach
2.1 Methodology
2.1.1 Research Programs
2.1.2 Market Size Estimation
2.1.3 Market Breakdown and Data Triangulation
2.2 Data Source
2.2.1 Secondary Sources
2.2.2 Primary Sources
Chapter 3. Market Dynamics and Competition Analysis
3.1 Market Drivers
3.1.1 Driver 1
3.1.2 Driver 2
3.2 Restraints and Challenges
3.2.1 Restraint 1
3.2.2 Restraint 2
3.3 Growth Opportunities
3.3.1 Opportunity 1
3.3.2 Opportunity 2
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of Substitute
3.4.4 Threat of New Entrants
3.4.5 Degree of Competition
3.5 Regulatory Compliance
3.6 Competitive Landscape, 2019
3.6.1 Player Positioning Analysis
3.6.2 Key Strategies Adopted By Leading Players
Chapter 4. Stroke Management Market By Type
4.1 Introduction
4.2 Global Stroke Management Revenue (US$ Mn) by Type
4.2.1 Global Stroke Management Market Revenue (US$ Mn) and Forecast By Type, 2016 – 2027
4.2.2 Ischemic
4.2.2.1 Ischemic Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
4.2.3 Hemorrhagic
4.2.3.1 Hemorrhagic Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
4.2.4 Transient ischemic attack (TIA)
4.2.4.1 Transient ischemic attack (TIA) Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
4.2.5 Others
4.2.5.1 Others Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
Chapter 5. Stroke Management Market By Diagnostics
5.1 Introduction
5.2 Global Stroke Management Revenue (US$ Mn) by Diagnostics
5.2.1 Global Stroke Management Market Revenue (US$ Mn) and Forecast By Diagnostics, 2016 – 2027
5.2.2 Magnetic resonance imaging (MRI)
5.2.2.1 Magnetic resonance imaging (MRI) Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
5.2.3 Computed tomography scan (CT scan)
5.2.3.1 Computed tomography scan (CT scan) Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
5.2.4 Electrocardiography
5.2.4.1 Electrocardiography Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
5.2.5 Carotid ultrasound
5.2.5.1 Carotid ultrasound Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
5.2.6 Cerebral angiography
5.2.6.1 Cerebral angiography Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
5.2.7 Others
5.2.7.1 Others Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
Chapter 6. Stroke Management Market By Therapeutic Devices
6.1 Introduction
6.2 Global Stroke Management Revenue (US$ Mn) by Therapeutic Devices
6.2.1 Global Stroke Management Market Revenue (US$ Mn) and Forecast By Therapeutic Devices, 2016 – 2027
6.2.2 Stent retriever
6.2.2.1 Stent retriever Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
6.2.3 Surgical clipping
6.2.3.1 Surgical clipping Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
6.2.4 Embolic Coils
6.2.4.1 Embolic Coils Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
6.2.5 Flow diverters
6.2.5.1 Flow diverters Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
6.2.6 Aspiration catheters
6.2.6.1 Aspiration catheters Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
6.2.7 Others
6.2.7.1 Others Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
Chapter 7. Stroke Management Market By End User
7.1 Introduction
7.2 Global Stroke Management Revenue (US$ Mn) by sales Channel
7.2.1 Global Stroke Management Market Revenue (US$ Mn) and Forecast By End User, 2016 – 2027
7.2.2 Hospitals
7.2.2.1 Hospitals Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
7.2.3 Ambulatory surgical centers
7.2.3.1 Ambulatory surgical centers Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
7.2.4 Diagnostic centers
7.2.4.1 Diagnostic centers Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
7.2.5 Others
7.2.5.1 Others Market Revenue (US$ Mn) and Growth Rate (%), 2016 - 2027
Chapter 8. North America Stroke Management Market By Country
8.1 North America Stroke Management Market Overview
8.2 U.S.
8.2.1 U.S. Stroke Management Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
8.2.2 U.S. Stroke Management Market Revenue (US$ Mn) and Forecast By Diagnostics, 2016 - 2027
8.2.3 U.S. Stroke Management Market Revenue (US$ Mn) and Forecast By Therapeutic Devices, 2016 - 2027
8.2.4 U.S. Stroke Management Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
8.3 Canada
8.3.1 Canada Stroke Management Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
8.3.2 Canada Stroke Management Market Revenue (US$ Mn) and Forecast By Diagnostics, 2016 - 2027
8.3.3 Canada Stroke Management Market Revenue (US$ Mn) and Forecast By Therapeutic Devices, 2016 - 2027
8.3.4 Canada Stroke Management Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
8.4 North America PEST Analysis
Chapter 9. Europe Stroke Management Market By Country
9.1 Europe Stroke Management Market Key Overview
9.2 UK
9.2.1 UK Stroke Management Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
9.2.2 UK Stroke Management Market Revenue (US$ Mn) and Forecast By Diagnostics, 2016 - 2027
9.2.3 UK Stroke Management Market Revenue (US$ Mn) and Forecast By Therapeutic Devices, 2016 - 2027
9.2.4 UK Stroke Management Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.3 Germany
9.3.1 Germany Stroke Management Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
9.3.2 Germany Stroke Management Market Revenue (US$ Mn) and Forecast By Diagnostics, 2016 - 2027
9.3.3 Germany Stroke Management Market Revenue (US$ Mn) and Forecast By Therapeutic Devices, 2016 - 2027
9.3.4 Germany Stroke Management Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.4 France
9.4.1 France Stroke Management Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
9.4.2 France Stroke Management Market Revenue (US$ Mn) and Forecast By Diagnostics, 2016 - 2027
9.4.3 France Stroke Management Market Revenue (US$ Mn) and Forecast By Therapeutic Devices, 2016 - 2027
9.4.4 France Stroke Management Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.5 Spain
9.5.1 Spain Stroke Management Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
9.5.2 Spain Stroke Management Market Revenue (US$ Mn) and Forecast By Diagnostics, 2016 - 2027
9.5.3 Spain Stroke Management Market Revenue (US$ Mn) and Forecast By Therapeutic Devices, 2016 - 2027
9.5.4 Spain Stroke Management Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.6 Rest of Europe
9.6.1 Rest of Europe Stroke Management Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
9.6.2 Rest of Europe Stroke Management Market Revenue (US$ Mn) and Forecast By Diagnostics, 2016 - 2027
9.6.3 Rest of Europe Stroke Management Market Revenue (US$ Mn) and Forecast By Therapeutic Devices, 2016 - 2027
9.6.4 Rest of Europe Stroke Management Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.7 Europe PEST Analysis
Chapter 10. Asia-Pacific Stroke Management Market By Country
10.1 Asia Pacific Stroke Management Market Overview
10.2 China
10.2.1 China Stroke Management Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.2.2 China Stroke Management Market Revenue (US$ Mn) and Forecast By Diagnostics, 2016 - 2027
10.2.3 China Stroke Management Market Revenue (US$ Mn) and Forecast By Therapeutic Devices, 2016 - 2027
10.2.4 China Stroke Management Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.3 Japan
10.3.1 Japan Stroke Management Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.3.2 Japan Stroke Management Market Revenue (US$ Mn) and Forecast By Diagnostics, 2016 - 2027
10.3.3 Japan Stroke Management Market Revenue (US$ Mn) and Forecast By Therapeutic Devices, 2016 - 2027
10.3.4 Japan Stroke Management Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.4 India
10.4.1 India Stroke Management Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.4.2 India Stroke Management Market Revenue (US$ Mn) and Forecast By Diagnostics, 2016 - 2027
10.4.3 India Stroke Management Market Revenue (US$ Mn) and Forecast By Therapeutic Devices, 2016 - 2027
10.4.4 India Stroke Management Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.5 Australia
10.5.1 Australia Stroke Management Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.5.2 Australia Stroke Management Market Revenue (US$ Mn) and Forecast By Diagnostics, 2016 - 2027
10.5.3 Australia Stroke Management Market Revenue (US$ Mn) and Forecast By Therapeutic Devices, 2016 - 2027
10.5.4 Australia Stroke Management Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.6 South Korea
10.6.1 South Korea Stroke Management Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.6.2 South Korea Stroke Management Market Revenue (US$ Mn) and Forecast By Diagnostics, 2016 - 2027
10.6.3 South Korea Stroke Management Market Revenue (US$ Mn) and Forecast By Therapeutic Devices, 2016 - 2027
10.6.4 South Korea Stroke Management Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.7 Rest of Asia-Pacific
10.7.1 Rest of Asia Pacific Stroke Management Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.7.2 Rest of Asia Pacific Stroke Management Market Revenue (US$ Mn) and Forecast By Diagnostics, 2016 - 2027
10.7.3 Rest of Asia Pacific Stroke Management Market Revenue (US$ Mn) and Forecast By Therapeutic Devices, 2016 - 2027
10.7.4 Rest of Asia Pacific Stroke Management Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.8 Asia Pacific PEST Analysis
Chapter 11. Latin America Stroke Management Market By Country
11.1 Latin America Stroke Management Market Overview
11.2 Brazil
11.2.1 Brazil Stroke Management Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.2.2 Brazil Stroke Management Market Revenue (US$ Mn) and Forecast By Diagnostics, 2016 - 2027
11.2.3 Brazil Stroke Management Market Revenue (US$ Mn) and Forecast By Therapeutic Devices, 2016 - 2027
11.2.4 Brazil Stroke Management Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
11.3 Mexico
11.3.1 Mexico Stroke Management Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.3.2 Mexico Stroke Management Market Revenue (US$ Mn) and Forecast By Diagnostics, 2016 - 2027
11.3.3 Mexico Stroke Management Market Revenue (US$ Mn) and Forecast By Therapeutic Devices, 2016 - 2027
11.3.4 Mexico Stroke Management Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
11.4 Rest of Latin America
11.4.1 Rest of Latin America Stroke Management Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.4.2 Rest of Latin America Stroke Management Market Revenue (US$ Mn) and Forecast By Diagnostics, 2016 - 2027
11.4.3 Rest of Latin America Stroke Management Market Revenue (US$ Mn) and Forecast By Therapeutic Devices, 2016 - 2027
11.4.4 Rest of Latin America Stroke Management Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
11.5 Latin America PEST Analysis
Chapter 12. Middle East & Africa Stroke Management Market By Country
12.1 Middle East & Africa Stroke Management Market Overview
12.2 Saudi Arabia
12.2.1 Saudi Arabia Stroke Management Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
12.2.2 Saudi Arabia Stroke Management Market Revenue (US$ Mn) and Forecast By Diagnostics, 2016 - 2027
12.2.3 Saudi Arabia Stroke Management Market Revenue (US$ Mn) and Forecast By Therapeutic Devices, 2016 - 2027
12.2.4 Saudi Arabia Stroke Management Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
12.3 UAE
12.3.1 UAE Stroke Management Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
12.3.2 UAE Stroke Management Market Revenue (US$ Mn) and Forecast By Diagnostics, 2016 - 2027
12.3.3 UAE Stroke Management Market Revenue (US$ Mn) and Forecast By Therapeutic Devices, 2016 - 2027
12.3.4 UAE Stroke Management Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
12.4 Rest of Middle East & Africa
12.4.1 Rest of Middle East & Africa Stroke Management Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
12.4.2 Rest of Middle East & Africa Stroke Management Market Revenue (US$ Mn) and Forecast By Diagnostics, 2016 - 2027
12.4.3 Rest of Middle East & Africa Stroke Management Market Revenue (US$ Mn) and Forecast By Therapeutic Devices, 2016 - 2027
12.4.4 Rest of Middle East & Africa Stroke Management Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
12.5 South Africa PEST Analysis
Chapter 13. Player Analysis of Stroke Management
13.1 Global Stroke Management Market Company Share Analysis
13.2 Competition Matrix
13.2.1 Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2 New Product Launches and Product Enhancements
13.2.3 Mergers And Acquisition In Global Stroke Management Market
13.2.4 Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
Chapter 14. Company Profile
14.1 Abbott Laboratories
14.1.1 Company Snapshot
14.1.2 Business Overview
14.1.3 Financial Overview
14.1.3.1 Revenue (US$ Mn), 2019
14.1.3.2 Abbott Laboratories 2019 Stroke Management Business Regional Distribution
14.1.4 Product/Service and Specifications
14.1.5 Recent Development & Business Strategy
14.1.6 Manufacturing Plant Footprint Analysis
14.2 B. Braun Melsungen
14.3 Johnson & Johnson
14.4 GE Healthcare
14.5 Asahi Intecc CO.
14.6 Boston Scientific
14.7 Siemens
14.8 Medtronic
14.9 Koninklijke Philips N.V.
14.10 Others
